[1] |
Cristaldi M, Mauceri R, Di Fede O,et al. Salivary biomarkers for oral squamous cell carcinoma diagnosis and follow-up:Current status and perspectives[J]. Front Physiol, 2019, 10:1476. DOI: 10.3389/fphys.2019.01476.
|
[2] |
Panarese I, Aquino G, Ronchi A,et al. Oral and Oropharyngeal squamous cell carcinoma:Prognostic and predictive parameters in the etiopathogenetic route[J]. Expert Rev Anticancer Ther, 2019, 19(2):105-119. DOI: 10.1080/14737140.2019.1561288.
|
[3] |
Sung H, Ferlay J, Siegel RL,et al. Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3):209-249. DOI: 10.3322/caac.21660.
|
[4] |
|
[5] |
Bloebaum M, Poort L, Böckmann R,et al. Survival after curative surgical treatment for primary oral squamous cell carcinoma[J]. J Craniomaxillofac Surg, 2014, 42(8):1572-1576. DOI: 10.1016/j.jcms.2014.01.046.
|
[6] |
Nandini DB, Rao RS, Hosmani J,et al. Novel therapies in the management of oral cancer:An update[J]. Dis Mon, 2020, 66(12):101036. DOI: 10.1016/j.disamonth.2020.101036.
|
[7] |
Bavle RM, Venugopal R, Konda P,et al. Molecular classification of oral squamous cell carcinoma[J]. J Clin Diagn Res, 2016, 10(9):ZE18-ZE21. DOI: 10.7860/JCDR/2016/19967.8565.
|
[8] |
Wang B, Zhang S, Yue K,et al. The recurrence and survival of oral squamous cell carcinoma:A report of 275 cases[J]. Chin J Cancer, 2013, 32(11):614-618. DOI: 10.5732/cjc.012.10219.
|
[9] |
|
[10] |
|
[11] |
Saliminejad K, Khorram Khorshid HR, Soleymani Fard S,et al. An overview of microRNAs:Biology,functions,therapeutics,and analysis methods[J]. J Cell Physiol, 2019, 234(5):5451-5465. DOI: 10.1002/jcp.27486.
|
[12] |
Ha M, Kim VN. Regulation of microRNA biogenesis[J]. Nat Rev Mol Cell Biol, 2014, 15(8):509-524. DOI: 10.1038/nrm3838.
|
[13] |
|
[14] |
Menderico Junior GM, Thérèse TR, Pasini FS,et al. MicroRNA-mediated extracellular matrix remodeling in squamous cell carcinoma of the oral cavity[J]. Head Neck, 2021, 43(8):2364-2376. DOI: 10.1002/hed.26686.
|
[15] |
Hedbäck N, Jensen DH, Specht L,et al. MiR-21 expression in the tumor stroma of oral squamous cell carcinoma:An independent biomarker of disease free survival[J]. PLoS One, 2014, 9(4):e95193. DOI: 10.1371/journal.pone.0095193.
|
[16] |
Mahmood N, Hanif M, Ahmed A,et al. Circulating miR-21 as a prognostic and predictive biomarker in oral squamous cell carcinoma[J]. Pak J Med Sci, 2019, 35(5):1408-1412. DOI: 10.12669/pjms.35.5.331.
|
[17] |
Ren W, Qiang C, Gao L,et al. Circulating microRNA-21(MIR-21)and phosphatase and tensin homolog(PTEN)are promising novel biomarkers for detection of oral squamous cell carcinoma[J]. Biomarkers, 2014, 19(7):590-596. DOI: 10.3109/1354750X.2014.955059.
|
[18] |
|
[19] |
Feng YH, Tsao CJ. Emerging role of microRNA-21 in cancer [J]. Biomed Rep, 2016, 5(4):395-402. DOI: 10.3892/br.2016.747.
|
[20] |
Tseng HH, Tseng YK, You JJ,et al. Next-generation sequencing for microRNA profiling:microRNA-21-3p promotes oral cancer metastasis[J]. Anticancer Res, 2017, 37(3):1059-1066. DOI: 10.21873/anticanres.11417.
|
[21] |
|
[22] |
Grivennikov SI, Karin M. Inflammatory cytokines in cancer:Tumour necrosis factor and interleukin 6 take the stage[J]. Ann Rheum Dis, 2011, 70 Suppl 1:i104-i108. DOI: 10.1136/ard.2010.140145.
|
[23] |
Xi J, Huang Q, Wang L,et al. miR-21 depletion in macrophages promotes tumoricidal polarization and enhances PD-1 immunotherapy[J]. Oncogene, 2018, 37(23):3151-3165. DOI: 10.1038/s41388-018-0178-3.
|
[24] |
He Q, Chen Z, Dong Q,et al. MicroRNA-21 regulates prostaglandin E2 signaling pathway by targeting 15-hydroxyprostaglandin dehydrogenase in tongue squamous cell carcinoma[J]. BMC Cancer, 2016, 16(1):685. DOI: 10.1186/s12885-016-2716-0.
|
[25] |
Pastushenko I, Blanpain C. EMT transition states during tumor progression and metastasis[J]. Trends Cell Biol, 2019, 29(3):212-226. DOI: 10.1016/j.tcb.2018.12.001.
|
[26] |
Ma C, Shi T, Qu Z,et al. CircRNA_ACAP2 suppresses EMT in head and neck squamous cell carcinoma by targeting the miR-21-5p/STAT3 signaling axis[J]. Front Oncol, 2020, 10:583682. DOI: 10.3389/fonc.2020.583682.
|
[27] |
Zeng B, Li Y, Jiang F,et al. LncRNA GAS5 suppresses proliferation,migration,invasion,and epithelial-mesenchymal transition in oral squamous cell carcinoma by regulating the miR-21/PTEN axis[J]. Exp Cell Res, 2019, 374(2):365-373. DOI: 10.1016/j.yexcr.2018.12.014.
|
[28] |
Lu X, Kang Y. Hypoxia and hypoxia-inducible factors:Master regulators of metastasis[J]. Clin Cancer Res, 2010, 16(24):5928-5935. DOI: 10.1016/j.trecan.2016.10.016.
|
[29] |
Ren W, Hou J, Yang C,et al. Extracellular vesicles secreted by hypoxia pre-challenged mesenchymal stem cells promote non-small cell lung cancer cell growth and mobility as well as macrophage M2 polarization via miR-21-5p delivery[J]. J Exp Clin Cancer Res, 2019, 38(1):62. DOI: 10.1186/s13046-019-1027-0.
|
[30] |
Li L, Li C, Wang S,et al. Exosomes derived from hypoxic oral squamous cell carcinoma cells deliver miR-21 to normoxic cells to elicit a prometastatic phenotype[J]. Cancer Res, 2016, 76(7):1770-1780. DOI: 10.1158/0008-5472.CAN-15-1625.
|
[31] |
Karimi A, Bahrami N, Sayedyahossein A,et al. Evaluation of circulating serum 3 types of microRNA as biomarkers of oral squamous cell carcinoma;A pilot study[J]. J Oral Pathol Med, 2020, 49(1):43-48. DOI: 10.1111/jop.12959.
|
[32] |
Singh P, Srivastava AN, Sharma R,et al. Circulating microRNA-21 expression as a novel serum biomarker for oral sub-mucous fibrosis and oral squamous cell carcinoma[J]. Asian Pac J Cancer Prev, 2018, 19(4):1053-1057. DOI: 10.22034/APJCP.2018.19.4.1053.
|
[33] |
Ishinaga H, He F, Hou B,et al. A longitudinal study on circulating miR-21 as a therapeutic effect marker in head and neck squamous cell carcinoma[J]. Carcinogenesis, 2019:bgz075. DOI: 10.1093/carcin/bgz075.
|
[34] |
Rapado-González Ó, López-López R, López-Cedrún JL,et al. Cell-Free microRNAs as potential oral cancer biomarkers:From diagnosis to therapy[J]. Cells, 2019, 8(12):1653. DOI: 10.3390/cells8121653.
|
[35] |
Al Rawi N, Elmabrouk N, Abu Kou R,et al. The role of differentially expressed salivary microRNA in oral squamous cell carcinoma. A systematic review[J]. Arch Oral Biol, 2021, 125:105108. DOI: 10.1016/j.archoralbio.2021.105108.
|
[36] |
|
[37] |
Zahran F, Ghalwash D, Shaker O,et al. Salivary microRNAs in oral cancer[J]. Oral Dis, 2015, 21(6):739-747. DOI: 10.1111/odi.12340.
|
[38] |
Mehdipour M, Shahidi M, Manifar S,et al. Diagnostic and prognostic relevance of salivary microRNA-21,-125a,-31 and - 200a levels in patients with oral lichen planus:A short report [J]. Cell Oncol(Dordr), 2018, 41(3):329-334. DOI: 10.1007/s13402-018-0372-x.
|
[39] |
Uma Maheswari TN, Nivedhitha MS, Ramani P. Expression profile of salivary micro RNA-21 and 31 in oral potentially malignant disorders[J]. Braz Oral Res, 2020, 34:e002. DOI: 10.1590/1807-3107bor-2020.vol34.0002.
|
[40] |
Yap T, Koo K, Cheng L,et al. Predicting the presence of oral squamous cell carcinoma using commonly dysregulated microrna in oral swirls[J]. Cancer Prev Res(Phila), 2018, 11(8):491-502. DOI: 10.1158/1940-6207.CAPR-17-0409.
|
[41] |
Yap T, Seers C, Koo K,et al. Non-invasive screening of a microRNA-based dysregulation signature in oral cancer and oral potentially malignant disorders[J]. Oral Oncol, 2019, 96:113-120. DOI: 10.1016/j.oraloncology.2019.07.013.
|
[42] |
Liu C, Tong Z, Tan J,et al. MicroRNA-21-5p targeting PDCD4 suppresses apoptosis via regulating the PI3K/AKT/FOXO1 signaling pathway in tongue squamous cell carcinoma[J]. Exp Ther Med, 2019, 18(5):3543-3551. DOI: 10.3892/etm.2019.7970.
|
[43] |
Lopes CB, Magalhães LL, Teófilo CR,et al. Differential expression of hsa-miR-221,hsa-miR-21,hsa-miR-135b,and hsa-miR-29c suggests a field effect in oral cancer[J]. BMC Cancer, 2018, 18(1):721. DOI: 10.1186/s12885-018-4631-z.
|
[44] |
Manikandan M, Deva Magendhra Rao AK, Rajkumar KS,et al. Altered levels of miR-21,miR-125b-2 *,miR-138,miR-155,miR-184,and miR-205 in oral squamous cell carcinoma and association with clinicopathological characteristics[J]. J Oral Pathol Med, 2015, 44(10):792-800. DOI: 10.1111/jop.12300.
|
[45] |
Li J, Huang H, Sun L,et al. MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor[J]. Clin Cancer Res, 2009, 15(12):3998-4008. DOI: 10.1158/1078-0432.CCR-08-3053.
|
[46] |
Rajan C, Roshan VGD, Khan I,et al. MiRNA expression profiling and emergence of new prognostic signature for oral squamous cell carcinoma[J]. Sci Rep, 2021, 11(1):7298. DOI: 10.1038/s41598-021-86316-w.
|
[47] |
Supic G, Zeljic K, Rankov AD,et al. miR-183 and miR-21 expression as biomarkers of progression and survival in tongue carcinoma patients[J]. Clin Oral Investig, 2018, 22(1):401-409. DOI: 10.1007/s00784-017-2126-y.
|
[48] |
Liu KYP, Zhu SY, Brooks D,et al. Tumor microRNA profile and prognostic value for lymph node metastasis in oral squamous cell carcinoma patients[J]. Oncotarget, 2020, 11(23):2204-2215. DOI: 10.18632/oncotarget.27616.
|
[49] |
Chen Z, Yu T, Cabay RJ,et al. miR-486-3p,miR-139-5p,and miR-21 as biomarkers for the detection of oral tongue squamous cell carcinoma[J]. Biomark Cancer, 2017, 9:1179299X170090 0001. DOI: 10.1177/1179299X1700900001.
|
[50] |
Yu EH, Tu HF, Wu CH,et al. MicroRNA-21 promotes perineural invasion and impacts survival in patients with oral carcinoma[J]. J Chin Med Assoc, 2017, 80(6):383-388. DOI: 10.1016/j.jcma.2017.01.003.
|
[51] |
Wan Y, Hoyle RG, Xie N,et al. A super-enhancer driven by FOSL1 controls miR-21-5p expression in head and neck squamous cell carcinoma[J]. Front Oncol, 2021, 11:656628. DOI: 10.3389/fonc.2021.656628.
|
[52] |
Rapado-González O, Martínez-Reglero C, Salgado-Barreira A,et al. miRNAs in liquid biopsy for oral squamous cell carcinoma diagnosis:Systematic review and meta-analysis[J]. Oral Oncol, 2019, 99:104465. DOI: 10.1016/j.oraloncology.2019.104465.
|
[53] |
Gigliotti J, Madathil S, Makhoul N. Delays in oral cavity cancer [J]. Int J Oral Maxillofac Surg, 2019, 48(9):1131-1137. DOI: 10.1016/j.ijom.2019.02.015.
|